GentiBio is a biotechnology company specializing in engineered regulatory T cells (Tregs) to treat autoimmune, alloimmune, and inflammatory diseases
GentiBio is a biotechnology company specializing in engineered regulatory T cells (Tregs) to treat autoimmune, alloimmune, and inflammatory diseases. Their proprietary platform enables the creation of potent, stable, and targeted Tregs tailored for specific diseases, addressing key challenges in Treg therapeutics.